Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Identification of Genetic Loci Associated With Intracerebral Hemorrhage Using a Multitrait Analysis Approach

  • Muiño, Elena|||0000-0001-5839-7328
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Cullell, Natalia|||0000-0001-5118-1014
  • Lledós, Miquel|||0000-0001-8832-789X
  • Martín-Campos, Jesús María|||0000-0003-0414-037X
  • Villatoro-González, Paula|||0009-0001-0287-4073
  • Sierra-Marcos, Alba|||0000-0001-6570-9318
  • Ros-Castelló, Victoria|||0000-0002-9523-3012
  • Aguilera-Simón, Ana|||0000-0003-1428-8212
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Background and Objectives Genome-wide association studies (GWASs) have only 2 loci associated with spontaneous intracerebral hemorrhage (ICH): APOE for lobar and 1q22 for nonlobar ICH. We aimed to discover new loci through an analysis that combines correlated traits (multi-trait analysis of GWAS [MTAG]) and explore a gene-based analysis, transcriptome-wide association study (TWAS), and proteome-wide association study (PWAS) to understand the biological mechanisms of spontaneous ICH providing potential therapeutic targets. Methods We use the published MTAG of ICH (patients with spontaneous intraparenchymal bleeding) and small-vessel ischemic stroke. For all ICH, lobar ICH, and nonlobar ICH, a pairwise MTAG combined ICH with traits related to cardiovascular risk factors, cerebrovascular diseases, or Alzheimer disease (AD). For the analysis, we assembled those traits with a genetic correlation ≥0.3. A new MTAG combining multiple traits was performed with those traits whose pairwise MTAG yielded new GWAS-significant single nucleotide polymorphisms (SNPs), with a posterior-probability of model 3 (GWAS-pairwise) ≥0.6. We perform TWAS and PWAS that correlate the genetic component of expression or protein levels with the genetic component of a trait. We use the ICH cohort from UK Biobank as replication. Results For all ICH (1,543 ICH, 1,711 controls), the mean age was 72 ± 2 in cases and 70 ± 2 in controls, and half of them were women. Replication cohort: 700 ICH and 399,717 controls. Novel loci were found only for all ICH (the trait containing lobar and nonlobar ICH), combining data of ICH and small vessel stroke, white matter hyperintensities volume, fractional anisotropy, mean diffusivity, and AD. We replicated 6 SNPs belonging to 2q33.2 (ICA1L, β = 0.20, SE = 0.03, p value = 8.91 × 10), 10q24.33 (OBFC1, β = -0.12, SE = 0.02, p value = 1.67 × 10), 13q34 (COL4A2, β = 0.02, SE = 0.02, p value = 2.34 × 10), and 19q13.32 (APOC1, β = -0.19, SE = 0.03, p value = 1.38 × 10; APOE, β = 0.21, SE = 0.03, p value = 2.70 × 10; PVRL2:CTB-129P6.4, β = 0.15, SE = 0.03, p value = 1.38 × 10); 2 genes (SH3PXD2A, Z-score = 4.83, p value = 6.67 × 10; and APOC1, Z-score: = 5.11, p value = 1.60 × 10); and ICA1L transcript (Z-score = 6.8, p value = 9.1 × 10) and protein levels (Z-score = -5.8, p value = 6.7 × 10).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

GRECOS Project (Genotyping Recurrence Risk of Stroke): the use of genetics to predict the vascular recurrence after stroke

  • Fernández-Cadenas, Israel
  • Mendióroz, Maite
  • Giralt, Dolors
  • Nafria, Cristina
  • García, Elena
  • Carrera, Caty
  • Gallego-Fábrega, Cristina
  • Domingues-Montanari, Sophie
  • Delgado, Pilar
  • Ribó, Marc
  • Castellanos, María del Mar
  • Martínez, Sergi
  • Freijo Guerrero, María del Mar
  • Jiménez-Conde, Jordi
  • Rubiera, Marta
  • Álvarez-Sabín, José
  • Molina, Carlos A.
  • Font, María A.
  • Grau Olivares, Marta
  • Palomeras, Ernest
  • Pérez de la Ossa, Natalia
  • Martínez-Zabaleta, Maite
  • Masjuan, Jaime
  • Moniche, Francisco
  • Cánovas, David
  • Piñana, Carlos
  • Purroy, Francisco
  • Cocho, Dolores
  • Navas, Inma
  • Tejero Juste, Carlos
  • Aymerich, Nuria
  • Cullell, Natalia
  • Muiño, Elena
  • Serena, Joaquín
  • Rubio, Francisco
  • Dávalos, Antoni
  • Roquer, Jaume
  • Arenillas, Juan
  • Martí-Fàbregas, Joan
  • Keene, Keith
  • Chen, Wei-Min
  • Worrall, Bradford B.
  • Sale, Michele
  • Arboix, Adriá
  • Krupinski, Jerzy
  • Montaner, Joan
[Abstract] Background and purpose: Vascular recurrence occurs in 11% of patients during the first year after ischemic stroke (IS) or transient ischemic attack. Clinical scores do not predict the whole vascular recurrence risk; therefore, we aimed to find genetic variants associated with recurrence that might improve the clinical predictive models in IS. Methods: We analyzed 256 polymorphisms from 115 candidate genes in 3 patient cohorts comprising 4482 IS or transient ischemic attack patients. The discovery cohort was prospectively recruited and included 1494 patients, 6.2% of them developed a new IS during the first year of follow-up. Replication analysis was performed in 2988 patients using SNPlex or HumanOmni1-Quad technology. We generated a predictive model using Cox regression (GRECOS score [Genotyping Reurrence Risk of Stroke]) and generated risk groups using a classification tree method. Results: The analyses revealed that rs1800801 in the MGP gene (hazard ratio, 1.33; P=9×10-03), a gene related to artery calcification, was associated with new IS during the first year of follow-up. This polymorphism was replicated in a Spanish cohort (n=1.305); however, it was not significantly associated in a North American cohort (n=1.683). The GRECOS score predicted new IS (P=3.2×10-09) and could classify patients, from low risk of stroke recurrence (1.9%) to high risk (12.6%). Moreover, the addition of genetic risk factors to the GRECOS score improves the prediction compared with previous Stroke Prognosis Instrument-II score (P=0.03). Conclusions: The use of genetics could be useful to estimate vascular recurrence risk after IS. Genetic variability in the MGP gene was associated with vascular recurrence in the Spanish population., This study was funded by Marato TV3, by the Spanish stroke research network (INVICTUS-PLUS) and by Generacion project (PI15/01978) Instituto de Salud Carlos III. I. F-C. is supported by the Miguel Servet programme (CP12/03298), Instituto de Salud Carlos III. Several groups participate in the International Stroke Genetics Consortium and the Spanish Stroke Genetics Consortium. The Hospital del Mar is supported by Spain’s Ministry of Health (III FEDER, RD12/0042/0020) Study recruitment and collection of datasets for the VISP trial were supported by a grant (R01 NS34447; PI James Toole) from the National Institute of Neurological Disorders and Stroke (NINDS). GWAS genotyping (U01 HG004438l; PI David Valle), funded by the National Human Genome Research institute and the Genomics and Randomized Trials (GARNET) Network (U01HG00516-03; co-PI Michèle M Sale & Bradford B Worrall), and genetic data cleaning was provided by the GARNET Coordinating Center (U01HG005157; PI Bruce S. Weir).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

DNA methylation levels are highly correlated between pooled samples and averaged values when analysed using the Infinium HumanMethylation450 BeadChip array

  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Carrera, Caty|||0000-0002-0804-0969
  • Muiño, Elena|||0000-0001-5839-7328
  • Montaner, Joan|||0000-0003-4845-2279
  • Krupinski, Jurek
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
DNA methylation is a heritable and stable epigenetic mark implicated in complex human traits. Epigenome-wide association studies (EWAS) using array-based technology are becoming widely used to identify differentially methylated sites associated with complex diseases. EWAS studies require large sample sizes to detect small effects, which increases project costs. In the present study we propose to pool DNA samples in methylation array studies as an affordable and accurate alternative to individual samples studies, in order to reduce economic costs or when low amounts of DNA are available. For this study, 20 individual DNA samples and 4 pooled DNA samples were analysed using the Illumina Infinium HumanMethylation450 BeadChip array to evaluate the efficiency of the pooling approach in EWAS studies. Statistical power calculations were also performed to discover the minimum sample size needed for the pooling strategy in EWAS. A total of 485,577 CpG sites across the whole genome were assessed. Comparison of methylation levels of all CpG sites between individual samples and their related pooled samples revealed highly significant correlations (rho.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

An Inflammatory Polymorphisms Risk Scoring System for the Differentiation of Ischemic Stroke Subtypes

  • Muiño, Elena|||0000-0001-5839-7328
  • Krupinski, Jurek
  • Carrera, Caty|||0000-0002-0804-0969
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Montaner, Joan|||0000-0003-4845-2279
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Inflammation has been associated with atherothrombotic stroke and recently with cardioembolic stroke. Different genetic risk factors have been specifically associated with the subtypes of ischemic stroke (cardioembolic, atherothrombotic, and lacunar). However, there are no studies that have generated genetic risk scores for the different subtypes of ischemic stroke using polymorphisms associated with inflammation. Methods. We have analyzed 68 polymorphisms of 30 inflammatory mediator genes in 2,685 subjects: 1,987 stroke cases and 698 controls. We generated a genetic scoring system with the most significant polymorphisms weighted by the odds ratio of every polymorphism and taken into consideration the stroke subtype. Results. Three polymorphisms, rs1205 (CRP gene), rs1800779, and rs2257073 (NOS3 gene), were associated with cardioembolic stroke (p value <0.05). The score generated was only associated with the cardioembolic stroke subtype (p value: 0.001) and was replicated in an independent cohort (p value: 0.017). The subjects with the highest score presented a cardioembolic stroke in 92.2% of the cases (p value: 0.002). Conclusion. The genetics of inflammatory markers is more closely associated with cardioembolic strokes than with atherothrombotic or lacunar strokes. The genetic risk scoring system could be useful in the prediction and differentiation of ischemic stroke; however, it might be specific to particular ischemic stroke subtypes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Automated quantification of cerebral edema following hemispheric infarction, Application of a machine-learning algorithm to evaluate CSF shifts on serial head CTs

  • Chen, Yasheng
  • Dhar, Rajat|||0000-0002-5167-5097
  • Heitsch, Laura
  • Ford, Andria
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Carrera, Caty|||0000-0002-0804-0969
  • Montaner, Joan|||0000-0003-4845-2279
  • Lin, Weili
  • Shen, Dinggang
  • An, Hongyu
  • Lee, Jin-Moo
Although cerebral edema is a major cause of death and deterioration following hemispheric stroke, there remains no validated biomarker that captures the full spectrum of this critical complication. We recently demonstrated that reduction in intracranial cerebrospinal fluid (CSF) volume (∆ CSF) on serial computed tomography (CT) scans provides an accurate measure of cerebral edema severity, which may aid in early triaging of stroke patients for craniectomy. However, application of such a volumetric approach would be too cumbersome to perform manually on serial scans in a real-world setting. We developed and validated an automated technique for CSF segmentation via integration of random forest (RF) based machine learning with geodesic active contour (GAC) segmentation. The proposed RF + GAC approach was compared to conventional Hounsfield Unit (HU) thresholding and RF segmentation methods using Dice similarity coefficient (DSC) and the correlation of volumetric measurements, with manual delineation serving as the ground truth. CSF spaces were outlined on scans performed at baseline (< 6 h after stroke onset) and early follow-up (FU) (closest to 24 h) in 38 acute ischemic stroke patients. RF performed significantly better than optimized HU thresholding (p < 10 - 4 in baseline and p < 10 - 5 in FU) and RF + GAC performed significantly better than RF (p < 10 - 3 in baseline and p < 10 - 5 in FU). Pearson correlation coefficients between the automatically detected ∆ CSF and the ground truth were r = 0.178 (p = 0.285), r = 0.876 (p < 10 - 6) and r = 0.879 (p < 10 - 6) for thresholding, RF and RF + GAC, respectively, with a slope closer to the line of identity in RF + GAC. When we applied the algorithm trained from images of one stroke center to segment CTs from another center, similar findings held. In conclusion, we have developed and validated an accurate automated approach to segment CSF and calculate its shifts on serial CT scans. This algorithm will allow us to efficiently and accurately measure the evolution of cerebral edema in future studies including large multi-site patient populations.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

GRECOS project (Genotyping Recurrence Risk of Stroke). The use of genetics to predict the vascular recurrence after stroke

  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Mendioroz, Maite|||0000-0002-4179-5781
  • Giralt, Dolors
  • Nafría, Cristina
  • Garcia, Elena
  • Carrera, Caty|||0000-0002-0804-0969
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Domingues-Montanari, Sophie
  • Delgado Martínez, María Pilar|||0000-0002-1628-4488
  • Ribo, Marc|||0000-0001-9242-043X
  • Castellanos, María del Mar|||0000-0003-3116-1352
  • Martínez, Sergi
  • Freijo, Mari Mar
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Rubiera, Marta
  • Álvarez Sabín, José|||0000-0002-8054-9209
  • Molina, Carlos A.|||0000-0001-6058-6259
  • Font, Maria Angels
  • Grau Olivares, Marta
  • Palomeras, Ernest|||0000-0002-0724-8653
  • Pérez de la Ossa, Natalia|||0000-0002-6063-211X
  • Martinez Zabaleta, Maite
  • Masjuan, Jaime|||0000-0003-1329-0943
  • Moniche, Francisco|||0000-0001-8613-2909
  • Cánovas Verge, David|||0000-0002-3483-8106
  • Piñana, Carlos|||0000-0001-7316-6202
  • Purroy, Francisco|||0000-0002-1808-5968
  • Cocho, Dolores
  • Navas, Inmaculada
  • Tejero, Carlos
  • Aymerich, Nuria
  • Cullell, Natalia|||0000-0001-5118-1014
  • Muiño, Elena|||0000-0001-5839-7328
  • Serena, Joaquín|||0000-0002-4478-7744
  • Rubio, Francisco
  • Dávalos, Antoni|||0000-0003-2949-5679
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Arenillas, Juan F.|||0000-0001-7464-6101
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Keene, Keith
  • Chen, Wei-Min
  • Worrall, Bradford
  • Sale, Michele
  • Arboix, Adrià|||0000-0002-8512-7881
  • Krupinski, Jerzy|||0000-0002-5136-8898
  • Montaner, Joan|||0000-0003-4845-2279
Background and Purpose-Vascular recurrence occurs in 11% of patients during the first year after ischemic stroke (IS) or transient ischemic attack (TIA). Clinical scores do not predict the whole vascular recurrence risk, therefore we aimed to find genetic variants associated with recurrence that might improve the clinical predictive mode is in IS. Methods-We analyzed 256 polymorphisms from 115 candidate genes in three patient cohorts comprising 4,482 IS or TIA patients. The discovery cohort was prospectively recruited and included 1,494 patients, 6.2% of them developed a new IS during the first year of follow-up. Replication analysis was performed in 2,988 patients using SNPlex or HumanOmni1-Quad technology. We generated a predictive model using Cox regression (GRECOS score), and generated risk groups using a classification tree method. Results-The analyses revealed that rs1800801 in the MGP gene (HR: 1.33, p= 9×10-03), a gene related to artery calcification, was associated with new IS during the first year of follow-up. This polymorphism was replicated in a Spanish cohort (n=1.305), however it was not significantly associated in a North American cohort (n=1.683). The GRECOS score predicted new IS (p=3.2×10-09) and could classify patients, from low risk of stroke recurrence (1.9%) to high risk (12.6%). Moreover, the addition of genetic risk factors to the GRECOS score improves the prediction compared to previous SPI-II score (p=0.03). Conclusions-The use of genetics could be useful to estimate vascular recurrence risk after IS. Genetic variability in the MGP gene was associated with vascular recurrence in the Spanish population.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Global DNA Methylation of Ischemic Stroke Subtypes

  • Soriano Tárraga, Carolina|||0000-0002-5635-273X
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Mola, Marina
  • Ois, Angel|||0000-0002-1375-5950
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Carrera, Caty|||0000-0002-0804-0969
  • Montaner, Joan|||0000-0003-4845-2279
  • Elosua, Roberto|||0000-0001-8235-0095
  • Roquer González, Jaume|||0000-0001-5992-2606
Ischemic stroke (IS), a heterogeneous multifactorial disorder, is among the leading causes of mortality and long-term disability in the western world. Epidemiological data provides evidence for a genetic component to the disease, but its epigenetic involvement is still largely unknown. Epigenetic mechanisms, such as DNA methylation, change over time and may be associated with aging processes and with modulation of the risk of various pathologies, such as cardiovascular disease and stroke. We analyzed 2 independent cohorts of IS patients. Global DNA methylation was measured by luminometric methylation assay (LUMA) of DNA blood samples. Univariate and multivariate regression analyses were used to assess the methylation differences between the 3 most common IS subtypes, large-artery atherosclerosis (LAA), small-artery disease (SAD), and cardio-aortic embolism (CE). A total of 485 IS patients from 2 independent hospital cohorts (n = 281 and n = 204) were included, distributed across 3 IS subtypes: LAA (78/281, 59/204), SAD (97/281, 53/204), and CE (106/281, 89/204). In univariate analyses, no statistical differences in LUMA levels were observed between the 3 etiologies in either cohort. Multivariate analysis, adjusted by age, sex, hyperlipidemia, and smoking habit, confirmed the lack of differences in methylation levels between the analyzed IS subtypes in both cohorts. Despite differences in pathogenesis, our results showed no global methylation differences between LAA, SAD, and CE subtypes of IS. Further work is required to establish whether the epigenetic mechanism of methylation might play a role in this complex disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

ICA1L Is Associated with Small Vessel Disease, A Proteome-Wide Association Study in Small Vessel Stroke and Intracerebral Haemorrhage

  • Cullell, Natalia|||0000-0001-5118-1014
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Muiño, Elena|||0000-0001-5839-7328
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Lledós, Miquel|||0000-0001-8832-789X
  • Martín-Campos, Jesús María|||0000-0003-0414-037X
  • Molina, Jessica
  • Casas, Laura
  • Almeria, Marta|||0000-0001-7445-6113
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Krupinski, Jerzy|||0000-0002-5136-8898
Small vessel strokes (SVS) and intracerebral haemorrhages (ICH) are acute outcomes of cerebral small vessel disease (SVD). Genetic studies combining both phenotypes have identified three loci associated with both traits. However, the genetic cis-regulation at the protein level associated with SVD has not been studied before. We performed a proteome-wide association study (PWAS) using FUSION to integrate a genome-wide association study (GWAS) and brain proteomic data to discover the common mechanisms regulating both SVS and ICH. Dorsolateral prefrontal cortex (dPFC) brain proteomes from the ROS/MAP study (N = 376 subjects and 1443 proteins) and the summary statistics for the SVS GWAS from the MEGASTROKE study (N = 237,511) and multi-trait analysis of GWAS (MTAG)-ICH-SVS from Chung et al. (N = 240,269) were selected. We performed PWAS and then a co-localization analysis with COLOC. The significant and nominal results were validated using a replication dPFC proteome (N = 152). The replicated results (q -value < 0.05) were further investigated for the causality relationship using summary data-based Mendelian randomization (SMR). One protein (ICA1L) was significantly associated with SVS (z-score = -4.42 and p -value = 9.6 × 10 -6) and non-lobar ICH (z-score = -4.8 and p -value = 1.58 × 10 -6) in the discovery PWAS, with a high co-localization posterior probability of 4. In the validation PWAS, ICA1L remained significantly associated with both traits. The SMR results for ICA1L indicated a causal association of protein expression levels in the brain with SVS (p -value = 3.66 × 10 -5) and non-lobar ICH (p -value = 1.81 × 10 -5). Our results show that the association of ICA1L with SVS and non-lobar ICH is conditioned by the cis-regulation of its protein levels in the brain.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Contribution of "Omic" studies to the understanding of CADASIL. A systematic review

  • Muiño, Elena|||0000-0001-5839-7328
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Arboix, Adrià|||0000-0002-8512-7881
CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) is a small vessel disease caused by mutations in NOTCH3 that lead to an odd number of cysteines in the epidermal growth factor (EGF)-like repeat domain, causing protein misfolding and aggregation. The main symptoms are migraines, psychiatric disorders, recurrent strokes, and dementia. Omic technologies allow the massive study of different molecules for understanding diseases in a non-biased manner or even for discovering targets and their possible treatments. We analyzed the progress in understanding CADASIL that has been made possible by omics sciences. For this purpose, we included studies that focused on CADASIL and used omics techniques, searching bibliographic resources, such as PubMed. We excluded studies with other phenotypes, such as migraine or leukodystrophies. A total of 18 articles were reviewed. Due to the high prevalence of NOTCH3 mutations considered pathogenic to date in genomic repositories, one can ask whether all of them produce CADASIL, different degrees of the disease, or whether they are just a risk factor for small vessel disease. Besides, proteomics and transcriptomics studies found that the molecules that are significantly altered in CADASIL are mainly related to cell adhesion, the cytoskeleton or extracellular matrix components, misfolding control, autophagia, angiogenesis, or the transforming growth factor β (TGFβ) signaling pathway. The omics studies performed on CADASIL have been useful for understanding the biological mechanisms and could be key factors for finding potential drug targets.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

  • Muiño, Elena|||0000-0001-5839-7328
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Carrera, Caty|||0000-0002-0804-0969
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Cullell, Natalia|||0000-0001-5118-1014
  • Lledós, Miquel|||0000-0001-8832-789X
  • Castillo, J.
  • Sobrino, Tomás|||0000-0002-9760-8690
  • Campos, Francisco|||0000-0001-8665-1039
  • Rodríguez-Castro, E.
  • Millán, M.
  • Muñoz-Narbona, Lucia|||0000-0002-0884-3024
  • Bustamante, Alejandro|||0000-0003-4390-8900
  • López-Cancio, E.
  • Ribó, M.
  • Álvarez Sabín, José|||0000-0002-8054-9209
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Soriano-Tárraga, C.
  • Vives-Bauza, C.
  • Diaz-Navarro, Rosa
  • Tur, Silvia
  • Obach, Víctor|||0000-0002-0518-1053
  • Arenillas, Juan F.|||0000-0001-7464-6101
  • Segura, T.
  • Serrano-Heras, G.
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Delgado Mederos, Raquel|||0000-0003-3737-7226
  • Camps-Renom, Pol|||0000-0001-6587-6271
  • Prats Sánchez, Luis Antonio|||0000-0002-3192-4631
  • Guisado-Alonso, Daniel|||0000-0002-5799-3184
  • Guasch Jiménez, Marina|||0000-0001-6024-8348
  • Marín-Bueno, Rebeca|||0000-0002-0354-6602
  • Martínez-Domeño, Alejandro|||0000-0002-9933-3192
  • Freijo-Guerrero, M.D.M.
  • Moniche, F.
  • Cabezas, Juan Antonio
  • Castellanos, M.
  • Krupinsky, J.
  • Strbian, D.
  • Tatlisumak, T.
  • Thijs, V.
  • Lemmens, R.
  • Slowik, Agnieszka
  • Pera, J.
  • Heitsch, Laura
  • Ibañez, Laura
  • Cruchaga, Carlos|||0000-0002-0276-2899
  • Dhar, R.
  • Lee, J.M.
  • Montaner, J.
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Stroke is one of the most common causes of death and disability. Reperfusion therapies are the only treatment available during the acute phase of stroke. Due to recent clinical trials, these therapies may increase their frequency of use by extending the time-window administration, which may lead to an increase in complications such as hemorrhagic transformation, with parenchymal hematoma (PH) being the more severe subtype, associated with higher mortality and disability rates. Our aim was to find genetic risk factors associated with PH, as that could provide molecular targets/pathways for their prevention/treatment and study its genetic correlations to find traits sharing genetic background. We performed a GWAS and meta-analysis, following standard quality controls and association analysis (fastGWAS), adjusting age, NIHSS, and principal components. FUMA was used to annotate, prioritize, visualize, and interpret the meta-analysis results. The total number of patients in the meta-analysis was 2034 (216 cases and 1818 controls). We found rs79770152 having a genome-wide significant association (beta 0.09, p-value 3.90 × 10) located in the RP11-362K2.2:RP11-767I20.1 gene and a suggestive variant (rs13297983: beta 0.07, p-value 6.10 × 10) located in PCSK5 associated with PH occurrence. The genetic correlation showed a shared genetic background of PH with Alzheimer's disease and white matter hyperintensities. In addition, genes containing the ten most significant associations have been related to aggregated amyloid-β, tau protein, white matter microstructure, inflammation, and matrix metalloproteinases.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Altered methylation pattern in EXOC4 is associated with stroke outcome, an epigenome-wide association study

  • Cullell, Natalia|||0000-0001-5118-1014
  • Soriano Tárraga, Carolina|||0000-0002-5635-273X
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Muiño, Elena|||0000-0001-5839-7328
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Lledós, Miquel|||0000-0001-8832-789X
  • Esteller, M.|||0000-0003-4490-6093
  • Castro de Moura, Manuel|||0000-0002-8488-5306
  • Montaner, Joan|||0000-0003-4845-2279
  • Rosell Novel, Anna|||0000-0003-1082-3599
  • Delgado Martínez, María Pilar|||0000-0002-1628-4488
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Krupinski, Jerzy|||0000-0002-5136-8898
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Background and purpose: The neurological course after stroke is highly variable and is determined by demographic, clinical and genetic factors. However, other heritable factors such as epigenetic DNA methylation could play a role in neurological changes after stroke. Methods: We performed a three-stage epigenome-wide association study to evaluate DNA methylation associated with the difference between the National Institutes of Health Stroke Scale (NIHSS) at baseline and at discharge (ΔNIHSS) in ischaemic stroke patients. DNA methylation data in the Discovery (n = 643) and Replication (n = 62) Cohorts were interrogated with the 450 K and EPIC BeadChip. Nominal CpG sites from the Discovery (p value < 10) were also evaluated in a meta-analysis of the Discovery and Replication cohorts, using a random-fixed effect model. Metabolic pathway enrichment was calculated with methylGSA. We integrated the methylation data with 1305 plasma protein expression levels measured by SOMAscan in 46 subjects and measured RNA expression with RT-PCR in a subgroup of 13 subjects. Specific cell-type methylation was assessed using EpiDISH. Results: The meta-analysis revealed an epigenome-wide significant association in EXOC4 (p value = 8.4 × 10) and in MERTK (p value = 1.56 × 10). Only the methylation in EXOC4 was also associated in the Discovery and in the Replication Cohorts (p value = 1.14 × 10 and p value = 1.3 × 10, respectively). EXOC4 methylation negatively correlated with the long-term outcome (coefficient = - 4.91) and showed a tendency towards a decrease in EXOC4 expression (rho = - 0.469, p value = 0.091). Pathway enrichment from the meta-analysis revealed significant associations related to the endocytosis and deubiquitination processes. Seventy-nine plasma proteins were differentially expressed in association with EXOC4 methylation. Pathway analysis of these proteins showed an enrichment in natural killer (NK) cell activation. The cell-type methylation analysis in blood also revealed a differential methylation in NK cells. Conclusions: DNA methylation of EXOC4 is associated with a worse neurological course after stroke. The results indicate a potential modulation of pathways involving endocytosis and NK cells regulation.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Genome-Wide Studies in Ischaemic Stroke, Are Genetics Only Useful for Finding Genes?

  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Muiño, Elena|||0000-0001-5839-7328
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Lledós, Miquel|||0000-0001-8832-789X
  • Martín-Campos, Jesús María|||0000-0003-0414-037X
  • Cullell, Natalia|||0000-0001-5118-1014
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Ischaemic stroke is a complex disease with some degree of heritability. This means that heritability factors, such as genetics, could be risk factors for ischaemic stroke. The era of genome-wide studies has revealed some of these heritable risk factors, although the data generated by these studies may also be useful in other disciplines. Analysis of these data can be used to understand the biological mechanisms associated with stroke risk and stroke outcome, to determine the causality between stroke and other diseases without the need for expensive clinical trials, or to find potential drug targets with higher success rates than other strategies. In this review we will discuss several of the most relevant studies regarding the genetics of ischaemic stroke and the potential use of the data generated.